A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2001
10/16/2001	US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group.
10/16/2001	CA2086244C Method of preparing a radioactive rhenium complex solution
10/16/2001	CA2015470C Fluorinated arachidonic acid derivatives
10/12/2001	CA2335109A1 Cxcr4 agonist treatment of hematopoietic cells
10/11/2001	WO2001075110A2 Mucin-1 specific binding members and methods of use thereof
10/11/2001	WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	WO2001075104A1 Novel protein, dna thereof and process for producing the same
10/11/2001	WO2001075081A1 Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase
10/11/2001	WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
10/11/2001	WO2001075074A1 Novel proteins
10/11/2001	WO2001075073A2 Prostate cell lines and their use
10/11/2001	WO2001075072A2 PRODUCTION OF TcR GAMMA DELTA T CELLS
10/11/2001	WO2001075066A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses
10/11/2001	WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	WO2001075055A2 A novel polypeptide, human quinoprotein reductase 9 and the polynucleotide encoding the polypeptide
10/11/2001	WO2001075038A2 A novel polypeptide - human atp- dependent serine protease 9 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001075019A2 A novel polypeptide - human ataxia - telangiectasia mutein 11 andthe polynucleotide encoding said polypeptide
10/11/2001	WO2001074999A2 A novel polypeptide - short chain dehydrogenase/reductase 14 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074993A2 A novel polypeptide - human zinc finger protein 17 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF
10/11/2001	WO2001074896A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	WO2001074894A1 A new polypeptide - human protein phosphatase 1 regulation protein 12 and the polynucleotide encoding it
10/11/2001	WO2001074892A1 A novel polypeptide-human prostate-specific membrane antibody protein 12 and a polynucleotide encoding the same
10/11/2001	WO2001074883A1 A novel polypeptide-human endoprotease 11 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074882A1 A novel polypeptide-human zinc finger protein 49 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074878A1 A novel polypeptide-human amyloid precursor protein 9 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074877A1 A novel polypeptide-human excitatory amino acid transporter 12 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074872A1 A novel polypeptide-human rna helicase 15 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074871A1 A novel polypeptide - human cyclic amp phosphodiesterases 13 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074870A1 A novel polypeptide-human alpha-galactosidase a-11 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074869A1 A novel polypeptide - human heat shock protein 15 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074868A1 A novel polypeptide-human zinc finger protein 10 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074867A1 A novel polypeptide-human proteolytic enzyme regulatory protein 11 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074866A1 A novel polypeptide-human zinc finger protein 72 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074865A1 A novel polypeptide - human zinc finger protein 10 and the polynucleotide encoding said polypeptide
10/11/2001	WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	WO2001074857A2 Methods and compositions for modulating integrin-mediated cell-cell interactions
10/11/2001	WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	WO2001074855A2 Compositions and methods for dendritic cell-based immunotherapy
10/11/2001	WO2001074849A2 Binding peptides for carcinoembryonic antigen (cea)
10/11/2001	WO2001074845A2 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
10/11/2001	WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	WO2001074840A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents
10/11/2001	WO2001074837A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/11/2001	WO2001074827A1 Phosphoramidate prodrugs
10/11/2001	WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001	WO2001074790A2 Novel compounds for enhancing chemotherapy
10/11/2001	WO2001074789A1 New (1-adamantylamino)pyrimidines and method of their preparation
10/11/2001	WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001	WO2001074775A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/11/2001	WO2001074766A1 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses
10/11/2001	WO2001074765A1 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
10/11/2001	WO2001074759A1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents
10/11/2001	WO2001074506A1 Extrusion die
10/11/2001	WO2001074413A1 Medical devices suitable for gene therapy regimens
10/11/2001	WO2001074404A2 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor
10/11/2001	WO2001074403A1 Combination of p53 gene and e1b-deleted p53 gene
10/11/2001	WO2001074402A2 Camptothecin conjugates
10/11/2001	WO2001074400A1 Transporters and drug delivery system by using the same
10/11/2001	WO2001074388A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
10/11/2001	WO2001074384A1 Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
10/11/2001	WO2001074382A1 Method of treatment using ligand-immunogen conjugates
10/11/2001	WO2001074381A2 Calpain inhibitors in cancer treatment
10/11/2001	WO2001074379A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	WO2001074377A1 Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy
10/11/2001	WO2001074369A1 Divided dose therapies with vascular damaging activity
10/11/2001	WO2001074368A1 Combination therapies with vascular damaging activity
10/11/2001	WO2001074366A1 Use of fulvestrant in the treatment of resistant breast cancer
10/11/2001	WO2001074362A1 Inhibition of cyclooxygenase-2 activity
10/11/2001	WO2001074360A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001	WO2001074359A1 Sigma receptor ligands and their medical uses
10/11/2001	WO2001074355A1 Method for treating cells resistant to antineoplastic agents
10/11/2001	WO2001074349A1 Butylnitrone containing compositons for inhibition of cancer development
10/11/2001	WO2001074346A2 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes
10/11/2001	WO2001074337A1 System for transporting active substances in a biological system
10/11/2001	WO2001074333A1 D and l etherlipid stereoisomers and liposomes
10/11/2001	WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis
10/11/2001	WO2001074296A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists
10/11/2001	WO2001074136A2 Telomerase inhibitor polynucleotides
10/11/2001	WO2001074128A2 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide
10/11/2001	WO2001066585A8 A new polypeptide-human protease regulatory protein 10 and the p olynucleotide encoding it
10/11/2001	WO2001066139A8 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
10/11/2001	WO2001049317A3 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/11/2001	WO2001048190A8 Therapeutic uses of lna-modified oligonucleotides
10/11/2001	WO2001036640A3 Human fgf-21 gene and gene expression products
10/11/2001	WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
10/11/2001	WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001	WO2001024763A3 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/11/2001	WO2001021799B1 Traf4 associated cell cycle proteins, compositions and methods of use
10/11/2001	WO2001021585A3 Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
10/11/2001	WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
10/11/2001	WO2001019826A3 Triazolopyrimidine derivatives
10/11/2001	WO2001015692A8 Methods and compositions for selective cancer chemotherapy
10/11/2001	WO2001012579A3 New stilbenes with vascular damaging activity
10/11/2001	WO2001007470A3 Human nervous system-associated proteins
10/11/2001	WO2001002377A9 Telomerase inhibitors and methods of their use
10/11/2001	WO2000076556A3 High dose radionuclide complexes for bone marrow suppression
10/11/2001	WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion

1 ... 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 ... 2211